image: An experimental anti-cancer drug also prevented the severe bone-loss that normally accompanies the disease. This material relates to a paper that appeared in the Ja. 25, 2017, issue of Science Translational Medicine, published by AAAS. The paper, by K. Andrade at University of Utah School of Medicine in Salt Lake City, UT, and colleagues was titled, 'RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis.' view more
Credit: K. Andrade <i>et al., Science Translational Medicine</i> (2017)